Category : Healthcare and Pharmaceutical

Workforce Development & Leadership

MedImpact Expands Leadership to Transform Pharmacy Benefits

Business WireJuly 24, 2025November 19, 2025

by Business WireJuly 24, 2025November 19, 20250129

Clinicians, innovators, and industry experts will join the current leadership to harness recent investments and initiatives to empower clients with unmatched choices, flexibility, and control...

Clinical Research, Pharma & Healthcare Financing

Kerecis to Present Fish-Tissue Graft at APMA 2025

Business WireJuly 24, 2025November 19, 2025

by Business WireJuly 24, 2025November 19, 20250132

SurgiBind® Tendon Protect designed for preserving motion in surgical tendon management procedures without substantial tissue loss Kerecis, the company pioneering the use of fish-tissue in...

Digital Health, Technology & Innovation

Iron Bow Sells SoldierPoint Digital Health to GovCIO

Business WireJuly 24, 2025November 19, 2025

by Business WireJuly 24, 2025November 19, 20250150

Iron Bow Technologies (Iron Bow), a leading provider of innovative IT solutions to government, commercial, education, and healthcare markets, today announced the sale of its...

Clinical Research, Pharma & Healthcare Financing

Unite Us & Nomi Health Partner to Streamline Medicaid Payments

Business WireJuly 24, 2025August 19, 2025

by Business WireJuly 24, 2025August 19, 20250143

New strategic partnership combines Unite Us’ robust billing and reimbursement functionality with Nomi Health’s payment infrastructure to streamline financial flows for critical community services Unite...

Clinical Research, Pharma & Healthcare Financing

LUNGevity Launches Citizen Scientist Program with New Funding

PR NewswireJuly 23, 2025August 19, 2025

by PR NewswireJuly 23, 2025August 19, 20250114

Program builds pipeline of patients and caregivers trained to be directly involved in research LUNGevity Foundation is proud to announce that we been approved for...

Public Health, Disease Prevention & Wellness

Taiho & Cullinan Present Zipalertinib Data at IASLC 2025 Conference

PR NewswireJuly 23, 2025November 19, 2025

by PR NewswireJuly 23, 2025November 19, 20250210

Taiho Oncology, Inc., and Cullinan Therapeutics, Inc., today announced the presentation of new data from zipalertinib REZILIENT1 and REZILIENT2 trials at the International Association of...

Clinical Research, Pharma & Healthcare Financing

Diakonos Doses First Patient in Phase 2 Trial of DOC1021 for GBM

PR NewswireJuly 23, 2025November 19, 2025

by PR NewswireJuly 23, 2025November 19, 20250122

Initial patient dosed at comprehensive cancer center City of Hope as Phase 2 trial prepares to expand to additional premier oncology centers nationwide Diakonos Oncology...

Workforce Development & Leadership

BEYFORTUS cuts RSV hospital & doctor visits by 87% in babies

PR NewswireJuly 23, 2025November 19, 2025

by PR NewswireJuly 23, 2025November 19, 20250127

The largest US real-world study of BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection successfully met both of its co-primary endpoints, demonstrating that BEYFORTUS provides protection for...

Healthcare Quality, Patient Safety & Policy

IDEAYA & Hengrui to Present IDE849 at IASLC 2025 Lung Cancer Conf

PR NewswireJuly 23, 2025November 19, 2025

by PR NewswireJuly 23, 2025November 19, 20250151

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui), a global pharmaceutical company focused on scientific and...

Clinical Research, Pharma & Healthcare Financing

Microcurrent Therapy Effective in Heart Failure: C-MIC II Trial

PR NewswireJuly 23, 2025November 19, 2025

by PR NewswireJuly 23, 2025November 19, 20250131

Berlin Heals and the C-MIC II Investigators today announced the publication of the C-MIC II trial results in the European Journal of Heart Failure. The study, titled “Cardio-microcurrent Device Treatment...

Clinical Research, Pharma & Healthcare Financing

Apnimed Reports Positive Phase 3 Results for Oral OSA Pill AD109

PR NewswireJuly 23, 2025November 19, 2025

by PR NewswireJuly 23, 2025November 19, 20250130

Apnimed, Inc., a pharmaceutical company advancing an industry-leading pipeline of first-in-class oral therapies that address the root causes of obstructive sleep apnea (OSA) and other...

Workforce Development & Leadership

CHG Healthcare Appoints Theresa O’Leary as CIO

Business WireJuly 22, 2025November 19, 2025

by Business WireJuly 22, 2025November 19, 20250138

New leader brings deep operations experience from her more than two decades at UPS CHG Healthcare, the nation’s leading physician and advanced practice workforce solutions...

Clinical Research, Pharma & Healthcare Financing

AstraZeneca to Invest $50B in US Medicine Manufacturing

Business WireJuly 22, 2025November 19, 2025

by Business WireJuly 22, 2025November 19, 20250105

Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US Cornerstone of investment is a proposed new...

Public Health, Disease Prevention & Wellness

30 Studies Show Significant Health Benefits of Almased

Business WireJuly 22, 2025August 1, 2025

by Business WireJuly 22, 2025August 1, 20250135

Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health...

Digital Health, Technology & Innovation

Erbe Launches FiAPC® Plus for Better Argon Plasma Control

Business WireJuly 22, 2025November 19, 2025

by Business WireJuly 22, 2025November 19, 20250167

Erbe Elektromedizin GmbH presents its latest innovation in electrosurgery: the FiAPC® plus probes. They are designed for use in gastrointestinal and pulmonary endoscopy. Building upon decades...